Why the study?
Tachycardiomyopathy is a potentially reversible cause of heart failure requiring a high index of suspicion, prompting this description of clinical profiles, treatment, and outcomes.
Does heart rate control therapy improve clinical symptoms and left ventricular ejection fraction in patients with tachycardiomyopathy?
Does heart rate control therapy improve clinical symptoms and left ventricular ejection fraction in patients with tachycardiomyopathy?
In patients with tachycardiomyopathy, restoring normal heart rhythm or controlling heart rate leads to significant clinical improvement and recovery of left ventricular ejection fraction.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for rate control in tachycardiomyopathy; prospective trials needed before practice change.
Background: Tachycardiomyopathy is a non-familial cause of heart failure that can be reversible. A high index of suspicion is necessary for its diagnosis and for a rational approach in the management of patients. Aims: To describe the clinical profile and verify the treatment and outcome of a series of cases of patients with tachycardiomyopathy. Methodology: Among patients without previous ventricular dysfunction, those with tachycardiomyopathy were identified. They underwent clinical evaluation, complementary diagnostic tests, treatment and clinical follow-up. Results: 10 patients had tachycardiomyopathy, mean age 64.5 ± 11.5 years, 6 women. The arrhythmias were atrial fibrillation with a high heart rate (80%); atrial tachycardia with high heart rate and frequent ventricular premature beats. Mean baseline heart rate was 110.2 bpm and the ejection fraction was 36.8%. For heart rate control, all were treated with beta-blockers, in association with digoxin in 6 patients. It was necessary to implant a pacemaker in VVI mode (V: ventricle is stimulated, V: ventricle sensed; I: inhibiting response) and ablation of the atrioventricular node in 2 patients with persistent atrial fibrillation. After a mean 27.6 months, the mean heart rate was 76.5 bpm (p <0.0001, paired t-test) and there was clinical improvement of all patients. There was an average increase of 9.6% in the left ventricular ejection fraction. Despite this, 4 patients still had ventricular dysfunction (3 of them developed comorbidities). Conclusion: In this series, the main cause of tachycardiomyopathy was atrial fibrillation with high heart rate. Similar to the description of literature, there was remission of symptoms with restore normal heart rhythm or control heart rate.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: